Book this year's International QA Conference now.
More informationJoin the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationPrice: USD ($) 12.00
Please note: payment is required before the ebooklet is sent via email. However if you need earlier access please contact publications@therqa.com.
VAT on Electronic Books is chargeable in the UK and EU. Please see the 'Booklet Terms and Conditions' for further details.
The purpose of this booklet is to provide some guidance on the quality oversight and operational aspects of PVAs for professionals working in PV, Legal, Regulatory Affairs and QA departments.
The booklet aims to provide you with:
• An overview of the types of agreement
• The items which you may need to consider when developing and implementing PVAs
• The items to consider and to prioritise for QA oversight
• A matrix of the typical clauses according to your agreement type.
Background/Purpose
Types of agreements
Quality oversight
RQA
Sandra Dunlavy, Astellas
Magda Daudin, Janssen
Andrew Cooper, GlaxoSmithKline
Kieran O’Donnell, TMC Pharma Thomas Henn, United Therapeutics Europe Ltd
JSQA
Tomoko Yanai, Santen Pharmaceutical Co., Ltd
Shigeo Suzuki, MSD K.K. Ayami Komatsu, Japan Tobacco INC.
Teiki Iwaoka, CAC Croit Corporation
Madoka Sasaki, Sumitomo Dainippon Pharma Co. Ltd.